Handan Central Hospital
15
2
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
20%
3 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
The Chinese Familial Alzheimer's Network
Role: collaborator
China Cognition and Aging Study
Role: collaborator
Isa-VRD in TIE HRMM
Role: collaborator
The Treatment of Shoulder-hand Syndrome in Hemiplegia Patients
Role: lead
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
Role: collaborator
Effect of Acupuncture and Herbal Medicine on Bowel Recovery After Abdominal Surgery
Role: collaborator
Artificial Intelligence-assisted Diagnosis
Role: collaborator
Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult
Role: collaborator
Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Role: collaborator
A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform
Role: collaborator
Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants
Role: collaborator
Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly
Role: collaborator
A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.
Role: collaborator
Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke
Role: collaborator
An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases
Role: collaborator
All 15 trials loaded